R. David Hoover Net Worth

The estimated Net Worth of R David Hoover is at least 8.85 百万$ dollars as of 6 March 2024. Mr. Hoover owns over 20,000 units of Elanco Animal Health Inc stock worth over 2,678,800$ and over the last 15 years he sold ELAN stock worth over 5,719,404$. In addition, he makes 456,006$ as Independent Chairman of the Board at Elanco Animal Health Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Hoover ELAN stock SEC Form 4 insiders trading

R has made over 90 trades of the Elanco Animal Health Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of ELAN stock worth 322,800$ on 6 March 2024.

The largest trade he's ever made was exercising 240,000 units of Elanco Animal Health Inc stock on 14 March 2016 worth over 5,244,000$. On average, R trades about 12,583 units every 22 days since 2009. As of 6 March 2024 he still owns at least 185,000 units of Elanco Animal Health Inc stock.

You can see the complete history of Mr. Hoover stock trades at the bottom of the page.

R. David Hoover biography

R. David Hoover is Independent Chairman of the Board of the Company. Mr. Hoover has served as the chairman of the Board since May 2018. Mr. Hoover has been retired since 2013. Prior to that, Mr. Hoover served in various roles at Ball Corporation, a company supplying innovative, sustainable packaging solutions and other technologies and services, including Chairman from 2002 to 2013, Chief Executive Officer from 2010 to 2011, President and Chief Executive Officer from 2001 to 2010, Chief Operating Officer from 2000 to 2001 and Chief Financial Officer from 1998 to 2000. Mr. Hoover currently serves on the board of directors of Edgewell Personal Care Company and has previously served on the board of directors of Ball Corporation and of Lilly. Mr. Hoover’s experience described above, including his extensive management experience as Chief Executive Officer and Chief Financial Officer at Ball Corporation and corporate governance experience through his service on other public boards, including nine years he previously served as a director for Lilly, provides him with the qualifications and skills to serve as a director on Elanco’s Board.

What is the salary of R Hoover?

As the Independent Chairman of the Board of Elanco Animal Health Inc, the total compensation of R Hoover at Elanco Animal Health Inc is 456,006$. There are 8 executives at Elanco Animal Health Inc getting paid more, with Jeffrey Simmons having the highest compensation of 15,801,800$.

How old is R Hoover?

R Hoover is 74, he's been the Independent Chairman of the Board of Elanco Animal Health Inc since 2018. There are no older and 28 younger executives at Elanco Animal Health Inc.

What's R Hoover's mailing address?

R's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.

Insiders trading at Elanco Animal Health Inc

Over the last 6 years, insiders at Elanco Animal Health Inc have traded over 1,626,280,000$ worth of Elanco Animal Health Inc stock and bought 657,104 units worth 14,225,149$ . The most active insiders traders include Aktiengesellschaft Bayer Wo...、Scott D.Sachem Head Capital...、R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of 14,011,833$. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth 51,975$.

What does Elanco Animal Health Inc do?

elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.

Complete history of Mr. Hoover stock trades at Ball、Lilly(Eli) & Co、Edgewell Personal Care Co、Elanco Animal Health Inc

Elanco Animal Health Inc executives and stock owners

Elanco Animal Health Inc executives and other stock owners filed with the SEC include:

• Jeffrey Simmons,
  President, Chief Executive Officer, Director
• Sarena Lin,
  Executive Vice President, Global Marketing, Corporate Strategy and Transformation
• David Kinard,
  Executive Vice President of Human Resources
• David Urbanek,
  Executive Vice President - Manufacturing, Quality
• Aaron Schacht,
  Executive Vice President - Innovation, Regulatory, Business Development
• Todd Young,
  Chief Financial Officer, Executive Vice President
• Jeffrey N. Simmons,
  Pres, CEO & Director
• Todd S. Young,
  Exec. VP of Corp. Governance and Strategy & CFO
• R. David Hoover,
  Independent Chairman of the Board
• Kapila Anand,
  Independent Director
• Lawrence Kurzius,
  Independent Director
• Michael Harrington,
  Independent Director
• John Bilbrey,
  Independent Director
• Denise Scots-Knight,
  Independent Director
• Kirk McDonald,
  Independent Director
• Deborah Kochevar,
  Independent Director
• Art Garcia,
  Independent Director
• Joshua Smiley,
  Independent Director
• Aarti Shah,
  Independent Director
• David Ricks,
  Independent Director
• Carl McMillian,
  Independent Director
• James Meer,
  Chief Accounting Officer, Vice President
• Ramiro Cabral,
  Executive Vice President - Elanco International
• Michael-Bryant Hicks,
  Executive Vice President, General Counsel, Corporate Secretary
• Larbi Van Lier,
  Sr. VP of Asia
• Shawn McKee,
  Sr. VP of U.S. Companion Animal
• David Alan Urbanek,
  Exec. VP of Manufacturing & Quality
• Ramiro Martin Cabral,
  Exec. VP of Elanco International
• Racquel Harris Mason,
  Exec. VP & Chief Marketing Officer
• Marcela A. Kirberger,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Tiffany Ann Kanaga,
  Head of Investor Relations
• David S. Kinard,
  Exec. VP of HR Corp. Affairs & Admin.
• Chris Keeley,
  Sr. VP & Chief Information Officer
• James M. Meer,
  VP & Chief Accounting Officer
• De Simas Jose Manuel Correia,
  SEE REMARKS
• Lilly & Co Eli,
  10% owner
• Timothy J Bettington,
  SEE REMARKS
• Aktiengesellschaft Bayer Wo...,
  
• Racquel Harris Mason,
  See Remarks
• Dirk Ehle,
  Ex VP & Pres Elanco Europe
• Joyce J. Lee,
  Ex VP Prs US Pet Hlth Com Op
• Rajeev A. Modi,
  SEE REMARKS
• Paul Herendeen,
  
• Marcela A. Kirberger,
  SEE REMARKS
• William F Doyle,
  
• Scott D.Sachem Head Capital...,
  
• Brabander Ellen De,
  SEE REMARKS
• Shiv O'neill,
  GC AND CORP SEC
• Grace Mc Ardle,
  EVP, MANUFACTURING AND QUALITY